Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorTakahashi, Jacqueline Aparecida-
Autor(es): dc.creatorBarbosa, Bianca Vianna Rodrigues-
Autor(es): dc.creatorLima, Matheus Thomaz Nogueira Silva-
Autor(es): dc.creatorCardoso, Patrícia Gomes-
Autor(es): dc.creatorContigli, Christiane-
Autor(es): dc.creatorPimenta, Lúcia Pinheiro Santos-
Data de aceite: dc.date.accessioned2026-02-09T12:52:07Z-
Data de disponibilização: dc.date.available2026-02-09T12:52:07Z-
Data de envio: dc.date.issued2022-05-27-
Data de envio: dc.date.issued2022-05-27-
Data de envio: dc.date.issued2020-
Fonte completa do material: dc.identifierhttps://repositorio.ufla.br/handle/1/50046-
Fonte completa do material: dc.identifierhttps://doi.org/10.1016/j.bmc.2021.116366-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1169851-
Descrição: dc.descriptionThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak, which started in late 2019, drove the scientific community to conduct innovative research to contain the spread of the pandemic and to care for those already affected. Since then, the search for new drugs that are effective against the virus has been strengthened. Featuring a relatively low cost of production under well-defined methods of cultivation, fungi have been providing a diversity of antiviral metabolites with unprecedented chemical structures. In this review, we present viral RNA infections highlighting SARS-CoV-2 morphogenesis and the infectious cycle, the targets of known antiviral drugs, and current developments in this area such as drug repurposing. We also explored the metabolic adaptability of fungi during fermentation to produce metabolites active against RNA viruses, along with their chemical structures, and mechanisms of action. Finally, the state of the art of research on SARS-CoV-2 inhibitors of fungal origin is reported, highlighting the metabolites selected by docking studies.-
Idioma: dc.languageen-
Publicador: dc.publisherElsevier-
Direitos: dc.rightsrestrictAccess-
???dc.source???: dc.sourceBioorganic & Medicinal Chemistry-
Palavras-chave: dc.subjectFungi secondary metabolites-
Palavras-chave: dc.subjectAntiviral compounds-
Palavras-chave: dc.subjectSARS-CoV-2-
Palavras-chave: dc.subjectMolecular docking-
Palavras-chave: dc.subjectDrug discovery-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectMetabólitos secundários de fungos-
Palavras-chave: dc.subjectCompostos antivirais-
Palavras-chave: dc.subjectDescoberta de drogas-
Título: dc.titleAntiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic-
Tipo de arquivo: dc.typeArtigo-
Aparece nas coleções:Repositório Institucional da Universidade Federal de Lavras (RIUFLA)

Não existem arquivos associados a este item.